Alpha-synuclein in peripheral tissues as a possible marker for neurological diseases and other medical conditions

FJ Jiménez-Jiménez, H Alonso-Navarro… - Biomolecules, 2023 - mdpi.com
The possible usefulness of alpha-synuclein (aSyn) determinations in peripheral tissues
(blood cells, salivary gland biopsies, olfactory mucosa, digestive tract, skin) and in biological …

Misfolded α-synuclein assessment in the skin and CSF by RT-QuIC in isolated REM sleep behavior disorder

A Iranzo, A Mammana, A Muñoz-Lopetegi… - Neurology, 2023 - AAN Enterprises
Background and Objectives Real-time quaking-induced conversion (RT-QuIC) assay detects
misfolded α-synuclein (AS) in the skin and CSF of patients with the synucleinopathies …

Combining skin and olfactory α-synuclein seed amplification assays (SAA)—towards biomarker-driven phenotyping in synucleinopathies

A Kuzkina, J Rößle, A Seger, C Panzer, A Kohl… - npj Parkinson's …, 2023 - nature.com
Seed amplification assays (SAA) are becoming commonly used in synucleinopathies to
detect α-synuclein aggregates. Studies in Parkinson's disease (PD) and isolated REM-sleep …

Introduction to exosome and its role in brain disorders

H Sharma, HK Rachamalla, N Mishra… - Exosomes Based Drug …, 2024 - Springer
Exosomes, which are small extracellular vehicles produced by a variety of cell types, have
emerged as key actors in intercellular communication due to their ability to transport a …

Dermal real‐time quaking‐induced conversion is a sensitive marker to confirm isolated rapid eye movement sleep behavior disorder as an early α‐synucleinopathy

A Kuzkina, C Panzer, A Seger, D Schmitt… - Movement …, 2023 - Wiley Online Library
Background Skin biopsy is a potential tool for the premortem confirmation of an α‐
synucleinopathy. Objective The aim was to assess the aggregation assay real‐time quaking …

α-Synuclein Induced the occurrence of RBD via Interaction with OX1R and modulated its degradation

JK Fan, MC Wang, HM Yang, JN Zhang, L Gu… - NeuroMolecular …, 2023 - Springer
Rapid eye movement (REM) sleep behavior disorder (RBD) is a powerful early sign of
Parkinson's disease (PD), but the pathogenetic mechanism involved in RBD remains largely …

Brain-first vs. body-first Parkinson's disease: An update on recent evidence

J Horsager, P Borghammer - Parkinsonism & Related Disorders, 2024 - Elsevier
We recently proposed a new disease model of Parkinson's disease–the a-Synuclein Origin
site and Connectome model. The model posits that the initial pathology starts either in the …

[HTML][HTML] α-Synuclein pathology from the body to the brain: so many seeds so close to the central soil

Y Yang, Z Zhang - Neural Regeneration Research, 2024 - journals.lww.com
Abstract α-Synuclein is a protein that mainly exists in the presynaptic terminals. Abnormal
folding and accumulation of α-synuclein are found in several neurodegenerative diseases …

α-synuclein antibody 5G4 identifies idiopathic REM-sleep behavior disorder in abdominal skin biopsies

Š Tóth, K Kulcsárová, M Maretta, A Kunová… - Parkinsonism & Related …, 2024 - Elsevier
Introduction Idiopathic REM-sleep behavior disorder (iRBD) is considered the most specific
prodromal marker of Parkinson's disease (PD). With the need to improve early detection of …

大脑外病理性α-突触核蛋白: 这么多种子离源泉这么近

Y Yang, Z Zhang - 中国神经再生研究(英文版), 2024 - sjzsyj.com.cn
α-突触核蛋白是一种主要存在于突触前末端的蛋白. 在包括帕金森病在内的多种神经退行性疾病
中, 已发现了α-突触核蛋白存在异常折叠和积聚. 聚集和高度磷酸化的α-突触核蛋白是大脑中 …